|
|
|
Vaccine Adverse Event Reporting System (VAERS) PublicationsAsatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine 2008. Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Event Reporting System, 1995–2005.* The Journal of Infectious Diseases 2008;197(S2):S170–S177. DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; VAERS Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006;24(6):703–707. Haber P, Patel M, Iskander J, Gargiullo P, Baggs J, Parashar U. Importance of On-time RotaTeq Vaccination and Long-term Active Surveillance: In Reply. Pediatrics 2008; 122:1154. Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar U; Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007 Pediatrics 2008; Volume 121:206-1212 Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Safety 2006;29(5):375–384. Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM, The VAERS Working Group. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1999-2007. Vaccine 2008. Pool V, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM; VAERS Team. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.* Pediatrics 2002;110(6):e71. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatric Infectious Disease Journal 2004;23(4):287&ndash:294. Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.* American Journal of Epidemiology 2001;154(11):1006–1012. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)United States, 19912001. MMWR 2003;52(1):1–24. *Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Page last reviewed: September 24, 2008
Page last updated: April 25, 2008 Content source: Immunization Safety Office |
|
||||||||||||
|